#GoldenCross $PTCT at 39.39 R5 HiLo 47% T1Y 50 buy fwdPE -40.6 DIV N/A #PTC Therap #stocks #trading #finance #market

2019-05-15
198 Views

Golden Cross detected for PTCT (PTC Therapeutics, In) at the close price of 39.39. Trading at a 47 % level between the 52week High (52.95) and 52week Low (27.53). The average analyst 1-year target price is 50.0 with an average buy and a score of 0.0.

Golden Cross
5 %
PTCT
39.39
PTC Therapeutics, In
HiLo
46.7 %
Support
35.87
Resistance
40.86
50DMA
37.19
200DMA
37.16
52week high
52.95
52week low
27.53
10DMA
38.25
20DMA
37.79
100 Mean
34.76
Volume
513680
AvgDayVol
800303
MarketCap
2301601024
EBITDA
-98758000
Revenue
262255008
PE
0.00
P2S
8.78
P2B
0.00
Dividend
0.00
Div Ex-Date

Further research links:

Marketwatch Yahoo Finance Google Finance StockTwits

You may be interested

HILO Index 100 Current 57.5 MA20 -729.17 Lower 405.91 Upper Bound #stocks #trading #markets #finance
Global Indicators,
6 views
Global Indicators,
6 views

HILO Index 100 Current 57.5 MA20 -729.17 Lower 405.91 Upper Bound #stocks #trading #markets #finance

Andreas Aigner - 2020-06-02

HILO Index 100 Current 57.5 MA20 -729.17 Lower 405.91 Upper Bound #stocks #trading #markets #finance x

Demark B/S Index -7.13 Avg 63.66 Std -2 Curr #stocks #trading #markets #finance
Global Indicators,
5 views
Global Indicators,
5 views

Demark B/S Index -7.13 Avg 63.66 Std -2 Curr #stocks #trading #markets #finance

Andreas Aigner - 2020-06-02

Demark B/S Index -7.13 Avg 63.66 Std -2 Curr #stocks #trading #markets #finance

50/200 DMA Index -17.15 Avg 31.95 Std 5 Curr #stocks #trading #markets #finance
Global Indicators,
8 views
Global Indicators,
8 views

50/200 DMA Index -17.15 Avg 31.95 Std 5 Curr #stocks #trading #markets #finance

Andreas Aigner - 2020-06-02

50/200 DMA Index -17.15 Avg 31.95 Std 5 Curr #stocks #trading #markets #finance x

Leave a Comment

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

We use Cookies to improve our Site. Your are agreeing to this by continuing to use our Site.